This article was prepared using automated systems that process publicly available information. It may contain inaccuracies or omissions and is provided for informational purposes only. Nothing herein constitutes financial, investment, legal, or tax advice.
ETHZilla, formerly 180 Life Sciences, has secured $425 million in PIPE financing backed by over 60 institutional and crypto-native investors. In an exclusive interview, incoming chairman McAndrew Rudisill outlines the firm’s Ethereum-focused yield strategy and commitment to avoiding altcoin diversification.
- ETHZilla's $425M PIPE financing includes participation from 60+ institutional and crypto-native investors like Polychain Capital and Lido.
- The firm will use Ethereum-based strategies (staking, lending, liquidity provisioning) to generate higher yields than traditional ETH staking.
- ETHZilla rejects altcoin diversification, betting on ETH's yield potential and on-chain asset growth to drive long-term appreciation.
📎 Related coverage from: cryptopotato.com
Other Tags: DeFi, Electric Capital, GSR, Lido, Polychain Capital